22nd Century Group, Inc. (NYSEMKT:XXII) Files An 8-K Regulation FD DisclosureItem 7.01. Regulation FD Disclosure.
On May 1, 2017, the Company issued a press release, a copy of which is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
Item 9.01(d). Financial Statements and Exhibits.
99.1 Press release, dated May 1, 2017.
About 22nd Century Group, Inc. (NYSEMKT:XXII)
22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on technology that allows increasing or decreasing the level of nicotine and other nicotinic alkaloids in tobacco plants, and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. It is engaged in various activities, including research and development of less harmful or modified risk tobacco products and tobacco plant varieties; development of X-22, a smoking cessation aid consisting of very low nicotine (VLN) cigarettes; manufacture, marketing and distribution of its RED SUN and MAGIC cigarettes; production of SPECTRUM research cigarettes for the National Institute on Drug Abuse (NIDA); contract manufacturing of third-party branded tobacco products, and research and development of plant varieties of hemp/cannabis, such as plants with low to no amounts of delta-9-tetrahydrocannabinol (THC), plants with high levels of cannabidiol (CBD), and other non-THC cannabinoids. 22nd Century Group, Inc. (NYSEMKT:XXII) Recent Trading Information
22nd Century Group, Inc. (NYSEMKT:XXII) closed its last trading session up +0.03 at 1.40 with 419,188 shares trading hands.